Only days after MD+DI reported Cardinal Health was embroiled in a Class I recall of its Cardinal branded Monoject syringes, FDA has moved to clarify its advice for clinicians specific to the recall.

Just a week after issuing a notice giving its most serious rating to Cardinal Health’s recall of certain syringes, the FDA has put out a letter to healthcare providers warning that the recall may not ...

The FDA has alerted healthcare providers not to use Cardinal Health (NYSE:CAH) Monoject syringes with syringe pumps and patient-controlled analgesia, or PCA, pumps until it further evaluates reports ...

Because of a change in manufacturing and rebranding, the syringes have different dimensions and were made by a new contract manufacturer. “The dimensional changes made to the Cardinal Health Monoject ...